Vascular risk and FDDNP-PET influence cognitive performance
Manuscript Number:
12-1903R2
Author(s):
Jorge R. Barrio, Susan Y. Bookheimer, Linda M. Ercoli, Vladimir Kepe, Helen Lavretsky, David A. Merrill, Karen J. Miller, Pushpa V. Raja, Nathan Saito, Prabha Siddarth, Gary W. Small
Disclosures
Jorge R. Barrio
Nothing to Disclose
Susan Y. Bookheimer
Consulting Fees:
Takeda Corp, consulting, < 5,000
Linda M. Ercoli
Consulting Fees:
Motion Picture and Television Home 2012
Lecture Fees:
Travel expenses paid only Assisted Living Concepts May 2012
Vladimir Kepe
Nothing to Disclose
Helen Lavretsky
Consulting Fees:
Lilly Pharma, Dey Pharma
Grants
Agency:
Forest Laboratories
Dates:
04/10-12/14
David A. Merrill
Nothing to Disclose
Karen J. Miller
Nothing to Disclose
Pushpa V. Raja
Nothing to Disclose
Nathan Saito
Nothing to Disclose
Prabha Siddarth
Nothing to Disclose
Gary W. Small
Consulting Fees:
Dakim, Lilly, Novartis, Pfizer, Janssen
Equity:
Dakim
Lecture Fees:
Novartis
Patents/Royalties
Disclosure statement
The University of California, Los Angeles, owns a U.S. patent (6,274,119) entitled ̢���Methods for Labeling Beta-Amyloid Plaques and Neurofibrillary Tangles,̢����_ that uses the approach outlined in this article. I am among the inventors, have received royalties, and may receive royalties on future sales